Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
XLV has gained ground on the week, but short sellers are pulling back faster than options traders are willing to follow.
Short interest in the healthcare ETF has fallen sharply. SI dropped 14% over the past week to 6.3% of free float, reversing part of the monthly build that had pushed the figure above 7% at its peak in early October. That climb had been the central story in last week's note, when SI was up 27.5% over a month and the borrow market was at its tightest in 52 weeks. The retreat this week is a meaningful change: it marks the first sustained cover since that September-into-October build began. Cost to borrow has continued to ease, falling a further 9.7% on the week to 0.67%, and availability has opened up to 27%, a far cry from the 3.4% reading on October 1 when the pool was essentially fully lent.
Options traders are less convinced the pressure has passed. The put/call ratio has climbed to 1.72, nearly 1.8 standard deviations above its 20-day average of 1.64, making this the most defensively skewed reading in recent weeks. That PCR level is elevated in absolute terms as well, well above the 52-week low of 0.47, though still a distance from the 2.67 peak. The signal is not dramatic, but it is consistent: options positioning has grown more cautious even as the short book shrinks, suggesting some investors are choosing hedges over outright short sales.
The ORTEX short score has eased off its recent highs, dropping from around 61 a week ago to 58.8, reflecting the reduced short interest and looser borrow conditions. That is still an elevated reading in absolute terms, above the midpoint of the 0-to-100 range, but the direction of travel has shifted. The score's decline over the past five sessions is the clearest data-point confirmation that the most stressed phase of the short positioning cycle may have passed.
Price action supports a more balanced picture for now. XLV closed at $169.66, up 1.5% on the week despite a 1.4% pullback on Tuesday. The one-month gain stands at 2.6%, broadly in line with the defensive rotation narrative that drove the ETF to a 52-week high in September. The top institutional holders, led by Managed Account Advisors with a 9% stake and JPMorgan with just over 5%, have not yet reported Q3-end positioning changes beyond the June 30 filings, so the ownership picture is a quarter behind the price action.
What to watch next is whether the put/call ratio follows the short score lower, or whether options demand for downside protection persists even as outright short positions unwind further.
See the live data behind this article on ORTEX.
Open XLV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
